Detalles de la búsqueda
1.
Enhancing global access to cancer medicines.
CA Cancer J Clin
; 70(2): 105-124, 2020 03.
Artículo
en Inglés
| MEDLINE | ID: mdl-32068901
2.
SIRT7 promotes lung cancer progression by destabilizing the tumor suppressor ARF.
Proc Natl Acad Sci U S A
; 121(25): e2409269121, 2024 Jun 18.
Artículo
en Inglés
| MEDLINE | ID: mdl-38870055
3.
3-year invasive disease-free survival with chemotherapy de-escalation using an 18F-FDG-PET-based, pathological complete response-adapted strategy in HER2-positive early breast cancer (PHERGain): a randomised, open-label, phase 2 trial.
Lancet
; 403(10437): 1649-1659, 2024 Apr 27.
Artículo
en Inglés
| MEDLINE | ID: mdl-38582092
4.
Trastuzumab deruxtecan versus trastuzumab emtansine in patients with HER2-positive metastatic breast cancer: updated results from DESTINY-Breast03, a randomised, open-label, phase 3 trial.
Lancet
; 401(10371): 105-117, 2023 01 14.
Artículo
en Inglés
| MEDLINE | ID: mdl-36495879
5.
Correlation between trophoblast cell-surface antigen-2 (Trop-2) expression and pathological complete response in patients with HER2-positive early breast cancer treated with neoadjuvant docetaxel, carboplatin, trastuzumab, and pertuzumab.
Breast Cancer Res Treat
; 205(3): 589-598, 2024 Jun.
Artículo
en Inglés
| MEDLINE | ID: mdl-38456970
6.
Clinicopathological and molecular predictors of [18F]FDG-PET disease detection in HER2-positive early breast cancer: RESPONSE, a substudy of the randomized PHERGain trial.
Eur J Nucl Med Mol Imaging
; 2024 Apr 08.
Artículo
en Inglés
| MEDLINE | ID: mdl-38587643
7.
Subclinical atherosclerosis and accelerated epigenetic age mediated by inflammation: a multi-omics study.
Eur Heart J
; 44(29): 2698-2709, 2023 08 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-37339167
8.
Lymphoepithelial cyst of the pancreas.
Rev Esp Enferm Dig
; 2024 Jan 11.
Artículo
en Inglés
| MEDLINE | ID: mdl-38205705
9.
Palbociclib with Fulvestrant or Letrozole in Endocrine-Sensitive Patients with HR-Positive/HER2-Negative Advanced Breast Cancer: A Detailed Safety Analysis of the Randomized PARSIFAL Trial.
Oncologist
; 28(1): 23-32, 2023 01 18.
Artículo
en Inglés
| MEDLINE | ID: mdl-36239405
10.
Polarimetric imaging for the detection of synthetic models of SARS-CoV-2: A proof of concept.
J Quant Spectrosc Radiat Transf
; 302: 108567, 2023 Jul.
Artículo
en Inglés
| MEDLINE | ID: mdl-36945203
11.
Effect of the Protein Corona Formation on Antibody Functionalized Liquid Lipid Nanocarriers.
Int J Mol Sci
; 24(23)2023 Nov 25.
Artículo
en Inglés
| MEDLINE | ID: mdl-38069079
12.
Hybrid-APC treatment for gastric vascular ectasia of atypical location after failed radiofrequency ablation.
Rev Esp Enferm Dig
; 2023 Jun 14.
Artículo
en Inglés
| MEDLINE | ID: mdl-37314122
13.
Explaining deep reinforcement learning decisions in complex multiagent settings: towards enabling automation in air traffic flow management.
Appl Intell (Dordr)
; 53(4): 4063-4098, 2023.
Artículo
en Inglés
| MEDLINE | ID: mdl-35694685
14.
Insulin Signaling Disruption and INF-γ Upregulation Induce Aß1-42 and Hyperphosphorylated-Tau Proteins Synthesis and Cell Death after Paraquat Treatment of Primary Hippocampal Cells.
Chem Res Toxicol
; 35(12): 2214-2218, 2022 12 19.
Artículo
en Inglés
| MEDLINE | ID: mdl-36394833
15.
Trastuzumab and pertuzumab without chemotherapy in early-stage HER2+ breast cancer: a plain language summary of the PHERGain study.
Future Oncol
; 18(33): 3677-3688, 2022 Oct.
Artículo
en Inglés
| MEDLINE | ID: mdl-36300423
16.
A phase 2 study for evaluating doxycycline 50 mg once daily and 100 mg once daily as preemptive treatment for skin toxicity in patients with metastatic colorectal cancer treated with an anti-EGFR and chemotherapy.
Support Care Cancer
; 30(10): 8081-8088, 2022 Oct.
Artículo
en Inglés
| MEDLINE | ID: mdl-35776185
17.
Moving average as a method of assessing risk of pressure injury using the COMHON index (Conscious level, Mobility, Hemodynamic, Oxygenation, Nutrition) for patients in intensive care units.
Aust Crit Care
; 35(6): 696-700, 2022 11.
Artículo
en Inglés
| MEDLINE | ID: mdl-34924247
18.
Chemotherapy de-escalation using an 18F-FDG-PET-based pathological response-adapted strategy in patients with HER2-positive early breast cancer (PHERGain): a multicentre, randomised, open-label, non-comparative, phase 2 trial.
Lancet Oncol
; 22(6): 858-871, 2021 06.
Artículo
en Inglés
| MEDLINE | ID: mdl-34019819
19.
Subcutaneous trastuzumab with pertuzumab and docetaxel in HER2-positive metastatic breast cancer: Final analysis of MetaPHER, a phase IIIb single-arm safety study.
Breast Cancer Res Treat
; 187(2): 467-476, 2021 Jun.
Artículo
en Inglés
| MEDLINE | ID: mdl-33748921
20.
Aryl Hydrocarbon Receptor Activation Produces Heat Shock Protein 90 and 70 Overexpression, Prostaglandin E2/Wnt/ß-Catenin Signaling Disruption, and Cell Proliferation in MCF-7 and MDA-MB-231 Cells after 24 h and 14 Days of Chlorpyrifos Treatment.
Chem Res Toxicol
; 34(9): 2019-2023, 2021 09 20.
Artículo
en Inglés
| MEDLINE | ID: mdl-34424684